Latest California Healthline Stories
Podcast: KHN’s ‘What The Health?’ Much Ado About Drug Prices
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
Trump Vows (Again) To Lower Drug Prices But Skeptics Doubt Much Will Change
President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
Consumers Brace For Premium Hikes While Lawmakers Grasp At Remedies
Health insurers’ initial premium requests indicate stiff price hikes for consumers, just as bipartisan talks in Congress fall flat.
Podcast: KHN’s ‘What The Health?’ The Politics Of Rising Premiums And Menu Labeling
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Margot Sanger-Katz of The New York Times and Anna Edney of Bloomberg News discuss the latest on the politics of rising premiums, GOP efforts to take back money from the Children’s Health Insurance Program, and the controversy over new rules requiring calorie information on menus. Plus for extra credit, the panelists recommend their favorite health stories of the week.
Midterm Elections Are Shaping Up To Be A Referendum On Trumpism
Even voters who say they are more enthusiastic about voting in this congressional election than in past ones are not motivated by any specific issue. But, according to a poll out Thursday, health care policies rank high among topics voters want candidates to address.
Podcast: KHN’s ‘What The Health?’ Medicaid, Privacy And Tom Price’s Return
Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Talking Points Memo discuss the latest on states’ efforts to reshape their Medicaid programs, the kerfuffle over President Donald Trump’s medical records and comments by former Health and Human Services Secretary Tom Price about Congress’ repeal of the Affordable Care Act’s “individual mandate” penalty. Rovner also interviews Harvard professor Robert Blendon about the complex politics of health in the coming midterm elections.
How A Drug Company Under Pressure For High Prices Ratchets Up Political Activity
Denmark-based drugmaker Novo Nordisk has invested more in lobbying and doubled political donations since 2015.
Podcast: KHN’s ‘What The Health?’ What’s Next For The VA?
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Anna Edney of Bloomberg News and Alice Ollstein of Talking Points Memo discuss the collapse of the nomination of White House physician Ronny Jackson to head the Department of Veterans Affairs. They also discuss new bipartisan congressional efforts to address the opioid epidemic. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
‘A Persistent Puzzle’: Californians Embrace Medicaid — But Food Stamps? Not So Much.
The Golden State ranks near the bottom in its enrollment of eligible people in the food assistance program known as SNAP. Now state officials want to tap its robust Medicaid rolls to boost SNAP signups.
Podcast: KHN’s ‘What The Health?’ Nothing In Health Care Ever Goes Away
In this episode of KHN’s “What the Health?” Sarah Jane Tribble of Kaiser Health News, Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Paige Winfield Cunningham of The Washington Post examine how even after Republicans failed to repeal and replace the Affordable Care Act, the health care debate continues to roil politics. They discuss how Republicans in Congress have shifted their ACA messaging and how the Democrats are looking to Medicare expansion. They also discuss state efforts to expand Medicaid and drug pricing. And they spend a moment talking about Congress’ push to do something about the opioid crisis.
